Integrated BioPharma Inc. (OTCMKTS:INBP – Get Free Report) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 4 shares, a growth of ∞ from the August 15th total of 0 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 12,617 shares, the days-to-cover ratio is currently 0.0 days.
Integrated BioPharma Price Performance
Shares of OTCMKTS:INBP opened at $0.17 on Tuesday. The stock has a market cap of $5.27 million, a price-to-earnings ratio of -2.43 and a beta of 0.40. The company has a 50 day moving average of $0.17 and a 200-day moving average of $0.22. Integrated BioPharma has a one year low of $0.14 and a one year high of $0.42.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.
See Also
- Five stocks we like better than Integrated BioPharma
- Navan’s Strong Quarter Meets an AI Spending Reality Check
- LightPath’s Defense Pivot Could Send Shares Higher
- Clearance to Climb: Why Allegiant Has Room to Fly
- 3 Defense Stocks Riding the High-Energy Laser Boom
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
